Harvard Bioscience, Inc.
HBIO
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as a range of instruments and accessories for tisā¦ read more
Healthcare
Medical Instruments & Supplies
24 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.66
Price+13.30%
$0.08
1Y
Price
Market Cap
$29.389m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+0.8%
EBITDA Margin-11.2%
Net Profit Margin+12.3%
Free Cash Flow MarginRevenue
$88.750m
-5.7%
1y CAGR-7.6%
3y CAGR-6.9%
5y CAGREarnings
-$57.406m
-362.8%
1y CAGR-187.3%
3y CAGR-941.5%
5y CAGREPS
-$1.30
-364.3%
1y CAGR-183.0%
3y CAGR-687.3%
5y CAGRBook Value
$15.733m
$80.093m
Assets$64.360m
Liabilities$43.314m
DebtDebt to Assets
54.1%
-0.9x
Debt to EBITDAFree Cash Flow
$4.920m
+508.6%
1y CAGR+1057.8%
3y CAGR+686.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company